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Abstract
Metabolite concentrations reflect the physiological states of tissues and cells. However, the role of metabolic changes in
species evolution is currently unknown. Here, we present a study of metabolome evolution conducted in three brain
regions and two non-neural tissues from humans, chimpanzees, macaque monkeys, and mice based on over 10,000
hydrophilic compounds. While chimpanzee, macaque, and mouse metabolomes diverge following the genetic distances
among species, we detect remarkable acceleration of metabolome evolution in human prefrontal cortex and skeletal
muscle affecting neural and energy metabolism pathways. These metabolic changes could not be attributed to
environmental conditions and were confirmed against the expression of their corresponding enzymes. We further
conducted muscle strength tests in humans, chimpanzees, and macaques. The results suggest that, while humans are
characterized by superior cognition, their muscular performance might be markedly inferior to that of chimpanzees and
macaque monkeys.
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Introduction
Metabolites, small molecules with molecular weight typically
less than 1,500 Daltons, encompass a broad range of compounds
that includes building blocks of proteins, nucleic acids, and lipid
membranes, energy and chemical group carriers, and neurotrans-
mitters and other signaling molecules. Changes in metabolite
concentrations closely reflect changes in the physiological states of
tissues and cells. Thus, knowledge of metabolite concentration
changes specific to human tissues may be instrumental to
understanding the molecular mechanisms underlying evolution
of the human phenotype. Genomic and gene expression surveys
have demonstrated how comparative studies of humans and
closely related primate species can lead to identification of
evolutionarily, physiologically, and medically relevant features
characteristic of humans [1,2], including changes related to
metabolism [3]. Indeed, several physiological features specific to
humans imply possible metabolic adaptations. For instance,
evolution of a large brain in humans, which consumes 20% of
the total body energy at rest, has been suggested to involve
changes in energy distribution among tissues, as well as adaptation
to a nutrition-rich diet [4,5]. Similarly, emergence of endurance
running in hominid ancestry [6] may have added another
constraint to human metabolic evolution.
Despite the potential significance of metabolic changes to
evolution of the human phenotype, few studies of human-specific
metabolic features exist. Previous studies, although limited to 21
and 118 metabolites measured in brains of humans, chimpanzees,
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and macaque monkeys, revealed extensive metabolite concentra-
tion differences among species affecting approximately 50% of the
assessed compounds [7,8]. To further deepen our understanding
of metabolite concentration changes accompanying recent human
evolution, as well as to shed light on the general dynamics of
metabolome evolution, we conducted a comprehensive metabo-
lome survey across five tissues of humans, chimpanzees, rhesus
monkeys, and laboratory mice based on over 10,000 metabolic
compounds. In each species, we examined metabolite concentra-
tions in three brain regions, prefrontal cortex (PFC), primary
visual cortex (V1), and cerebellar cortex (CBC), as well as in the
kidney cortex and thigh skeletal muscle of 14 adult healthy
individuals (Table S1). Small molecules present in the tissue
samples were assayed using the following methodologies: (i) gas
chromatography-mass spectrometry (GC-MS), (ii) positive mode
liquid chromatography-mass spectrometry ([+]LC-MS), and (iii)
negative mode liquid chromatography-mass spectrometry ([2]LC-
MS). The effects of postmortem delay, as well as environmental
effects characteristic of the industrialized human lifestyle—a diet
rich in fat and sugar content, low levels of exercise, and high levels
of social stress—were assessed using the same set of metabolite
measurements in 14 additional macaque monkeys (Table S2). In
total, metabolite measurements were performed in 365 tissue
samples. To test the reliability of metabolite measurements further,
a subset of samples from four individuals per species per tissue was
measured using capillary electrophoresis-mass spectrometry (CE-
MS) as an alternative procedure. Metabolic measurements were
accompanied by the measurements of the expression of enzymes
using RNA-sequencing (RNA-seq) in a subset of 120 tissue
samples.
Results
Metabolome Quantification
Across these datasets, we quantified a total of 10,615 peaks
(mass spectrometry features), which were detected in at least one
tissue of one species (Figure 1a). Among them, 1,535 could be
annotated using metabolite standards or computationally match-
ing the metabolite features to metabolite database entries. As all
human and most chimpanzee samples were not collected
immediately after death, we removed from further analysis 636
peaks with concentrations affected by postmortem delay (Table
S3). These peaks were identified in comparison between macaque
samples collected with (n=2) and without (n=17) postmortem
delay (q,0.01 in at least one tissue, Figure S1). Out of 371
metabolites detected in the independent CE-MS experiment, 265
were detected by the LC-MS and GC-MS methodologies. The
concentration profiles of these metabolites across the different
species showed significant agreement among methodologies in all
tested tissues (Wilcoxon test, p,0.001, Figure S2).
Examination of metabolite concentration variation by means of
principal component analysis (PCA) showed a clear separation of
samples of all four species according to the three major organs—
brain, kidney, and muscle—in each dataset (Figure 1b, Figure S3).
Within each tissue we could further observe grouping according to
species identity (Figure 1c). Accordingly, of the 10,615
detected metabolite peaks, 92% showed significant concentration
differences among tissues (permutation p,0.01, false discovery
Figure 1. Metabolome data quantification, annotation, and variation analysis. (a) The total number of metabolite peaks measured in our
datasets. The bottom part of each bar indicates the number of peaks that were annotated in respective datasets. The total numbers of peaks and
numbers of annotated peaks are indicated above the bars. (b) PCA plot based on normalized intensities of 10,615 peaks from all metabolic datasets
measured in five tissues of the four species. Each circle represents an individual sample colored according to the tissue. (c) PCA plots for each of the
five tissues: muscle, kidney, PFC, CBC and V1. Each circle represents an individual sample colored according to species. (d) Percentages of peaks with
a significant proportion of variation (ANOVA, permutation p,0.01) explained by tissue, species, species–tissue interaction term (sp:ts), sex, age, and
sample RNA preservation. RIN, RNA Integrity Number.
doi:10.1371/journal.pbio.1001871.g001
Author Summary
Physiological processes that maintain our tissues’ func-
tionality involve the generation of multiple products and
intermediates known as metabolites—small molecules
with a weight of less than 1,500 Daltons. Changes in
concentrations of these metabolites are thought to be
closely related to changes in phenotype. Here, we assessed
concentrations of more than 10,000 metabolites in three
brain regions and two non-neural tissues (skeletal muscle
and kidney) of humans, chimpanzees, macaque monkeys,
and mice using mass spectrometry-based approaches. We
found that the evolution of the metabolome largely
reflects genetic divergence between species and is not
greatly affected by environmental factors. In the human
lineage, however, we observed an exceptional acceleration
of metabolome evolution in the prefrontal cortical region
of the brain and in skeletal muscle. Based on additional
behavioral tests, we further show that metabolic changes
in human muscle seem to be paralleled by a drastic
reduction in muscle strength. The observed rapid meta-
bolic changes in brain and muscle, together with the
unique human cognitive skills and low muscle perfor-
mance, might reflect parallel mechanisms in human
evolution.
Human Metabolome Evolution
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rate (FDR),1%), using analysis of variance (ANOVA). Further,
80% of peaks showed significant concentration differences among
the four species and 61% among primates (permutation p,0.01,
FDR,2%), indicating large scope and potential functional
importance of metabolome divergence among species. By contrast,
the effects of sex, age, and tissue preservation on metabolite
concentration variation were substantially smaller: on average ,1,
12, and 8% of all the assayed metabolite peaks were affected by
one of these factors, respectively (Figure 1d, Table S4).
Metabolome Differences among Tissues
To examine the metabolic differences among tissues further, we
sorted 9,603 metabolite peaks that showed significant concentra-
tion differences among the tissues into 13 metabolite clusters using
nonsupervised hierarchical clustering (Figure 2a, Figure S4). Most
of the clusters contained metabolite concentration profiles specific
to a given tissue (Figure S5). The largest proportion of metabolite
concentration profiles was muscle-specific (41%), almost 2-fold
more than brain-specific (23%) and kidney-specific (18%).
All clusters contained metabolic changes enriched in specific
pathways (permutation p,0.01), many of them associated with
known tissue-specific functions (Table S5). To test whether the
metabolite concentration differences among tissues could be
confirmed against differences in the expression of their corre-
sponding enzymes, we measured transcript levels in 120 of the 365
tissue samples using RNA-seq (Tables S1, S6). In this dataset we
detected expression of 17,913 protein-coding genes that could be
mapped among primate species (16,398 between primates and
mouse), with 3,820 (3,720) of them linked to metabolites based on
the Human Metabolome Database Version 3.0 (HMDB) annota-
tion (Figure S6). By combining metabolite concentration and
gene expression measurements, we showed that pathways
containing excess of tissue-specific metabolic profiles also showed
significant over-representation of corresponding tissue-specific
gene expression profiles in all 13 metabolite clusters (permutation
p,0.05, Figure 2c). Specifically, clusters containing metabolites
and enzymes showing brain-specific profiles were enriched for,
among others, neuroactive ligand-receptor interaction and the
synaptic vesicle cycle; muscle-specific profiles for glycolysis/
gluconeogenesis and oxidative phosphorylation; and kidney-
specific profiles for aldosterone-regulated water reabsorption
(Table S5). Thus, metabolite concentration differences among
tissues could be confirmed by expression-level differences in
corresponding genes, and these metabolite concentration differ-
ences represent some of the known functional properties of the
tissues.
Metabolome Divergence among Species
To inspect metabolic divergence among species, we sorted
9,356 metabolite peaks that showed significant concentration
differences among the four species (ANOVA, species or tissue–
species terms, permutation p,0.01, FDR,2%) into species-
specific categories within each of the five tissues, as well as within
composite tissue categories: cerebral cortex (PFC+V1) and brain
(PFC+V1+CBC). The greater number of samples belonging to
cerebral cortex and brain, compared with individual tissue
categories, results in the greater statistical power of tests performed
on these composite tissue samples. For this reason, throughout the
study we compared the relative proportions of change among
species within each tissue, without comparing the differences in
species-specific change among composite and individual tissues. As
a result, we found that in all tissues metabolic divergence on the
chimpanzee, macaque, and mouse evolutionary lineages could to a
large extent be explained by genetic distances among these species
[9] (Pearson r2=0.88, n=21, p,0.01). By contrast, the extent of
metabolic divergence on the human evolutionary lineage differed
substantially among tissues (Figure 3a,b; Figure S7). Human-
specific metabolic divergence in the V1 cortical region and kidney
was similar to chimpanzee-specific divergence in these tissues and
could be predicted from regression fit of metabolic divergence
based on phylogenetic divergence times of the three nonhuman
species (Figure 3a). By contrast, in the brain, PFC, and skeletal
muscle, human-specific metabolic divergence exceeded chimpan-
zee-specific divergence by 4.0-, 4.2-, and 8.4-fold respectively. This
excess was significantly greater than expected from phylogenetic
time-based divergence estimates (linear regression p,0.01). In fact,
human-specific metabolic divergence in the sampled thigh skeletal
muscle (mainly vastus lateralis) and PFC exceeded average
metabolic divergence seen in the mouse tissues. This indicates
that during the last 6–7 million years of human evolution, human
muscle metabolome underwent greater change than the mouse
metabolome did over the approximately 130 million years
separating mice from the common ancestor of humans, chimpan-
zees, and macaques.
The remarkable excess of human-specific metabolic divergence
in the skeletal muscle, PFC, and in the brain as a whole, but not in
V1 or the kidney, could be clearly visualized when grouping all
species-specific metabolic changes found on the human, chimpan-
zee, and macaque evolutionary lineages (Figure 3c, Table S7).
This result was also observed for the three mass spectrometry
datasets analyzed separately, was robust at various statistical
significance cutoffs, could be validated by metabolite measure-
ments overlapping between LC- and GC-MS techniques, was
Figure 2. Tissue-specific metabolite clusters. (a) Dendrogram of
9,603 metabolite peaks after hierarchical clustering, based on concen-
tration profile correlations across tissues in all four species. The colors
represent 13 metabolite clusters colored according to the tissue-
specificity of the cluster concentration profiles: shades of red indicating
brain-specific clusters, shades of blue: muscle-specific, and shades of
green: kidney-specific clusters. Clusters cumulatively containing less
than 10% of all assayed peaks were removed from further analyses and
are colored in gray. (b) Proportions of peaks specific to a given tissue
based on the cluster analysis. Colors of the bars correspond to the
colors of clusters in panel a. (c) Numbers of pathways with significant
enrichment of metabolites in the 13 metabolite clusters. The red part of
each bar shows pathways with significant overrepresentation of
enzymes with matching tissue-specific expression profiles.
doi:10.1371/journal.pbio.1001871.g002
Human Metabolome Evolution
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valid for both annotated and unannotated metabolite peaks,
and was not affected by exclusion of metabolites with low
concentration levels (Tables S8, S9, S10, Figures S8, S9). More
importantly, human-specific metabolic changes showed significant
agreement with expression profiles of the linked metabolic
enzymes in all tissues except one (CBC, Figure 3d). Similarly,
significant agreement between metabolite concentration and
enzyme expression profiles was seen on the macaque evolutionary
lineage for tissues containing large numbers of macaque-specific
metabolic changes: V1, kidney, cerebral cortex, whole brain, and
skeletal muscle.
All groups of metabolites showing species-specific concentra-
tion levels in different tissues were significantly enriched in
metabolic pathways from Kyoto Encyclopedia of Genes and
Genomes (KEGG) database resource (permutation p,0.01,
Table S11). Of the 115 KEGG pathways containing an excess
of species-specific metabolic changes, 100 contained at least one
enzyme showing a consistent species-specific expression pattern
in the RNA-seq data. Furthermore, in 61 of the 100 pathways,
the metabolites and enzymes that showed consistent species-
specific profiles were directly linked, while only 12 pathways
would be expected by chance (permutation p,0.01). At the
individual pathway level, 44 pathways contained significant
excess of enzymes with matching species-specific expression
profiles either directly or indirectly linked to the corresponding
species-specific metabolites (permutation p,0.01, Table S11)
while only seven pathways would be expected by chance
(permutation p,0.01).
Figure 3. Species-specific metabolic change. (a) Proportions of metabolite concentration changes on the four species evolutionary lineages.
The phylogenetic tree above the bars shows the human (red) and chimpanzee (orange) evolutionary lineages, the lineage connecting the common
ancestor of humans and chimpanzees with macaques (gray), and the lineage connecting the common ancestor of humans, chimpanzees, and
macaques with mice (blue). The colors within the bars show proportions of metabolite peaks with concentration changes specific to the
corresponding lineages. (b) Relationship between species-specific metabolite concentration divergence in each tissue and the corresponding
phylogenetic distances in million years (MY). The linear regression between metabolite concentration divergence and phylogenetic distances
represented by the dashed line was calculated based on the proportions of metabolite peaks with significant concentration divergence on the
corresponding lineage for the three nonhuman species (represented by circles). Asterisks colored according to the tissues show the proportions of
metabolite peaks with significant concentration divergence on the human lineage relative to the chimpanzee linage. (c) Heat map of relative
metabolite concentration levels across three primate species. The plot is based on the 4,698 metabolite peaks that showed significant concentration
differences in any tissue in the three primate species (t-test, permutation p,0.01). The columns represent metabolite peaks; the rows represent 190
tissue samples sorted by species and tissue identity. For each peak, concentration level in a given sample was normalized to the concentration across
all samples of other primate species within the same tissue (base 2 logarithm-transformed ratios). The colors show positive (red) and negative (blue)
concentration differences from the mean expression level. Concentration levels, p-values and annotation of the peaks shown in the Figure are listed
in Table S7. (d) Proportions of enzymes with matching species-specific expression profiles linked to species-specific metabolites in a given tissue
normalized by the number of enzymes with expression profiles specific to any species in this tissue. Tissues showing significant overrepresentation of
enzymes with matching species-specific expression profiles are indicated with asterisks: **, p,0.01 and *, p,0.05.
doi:10.1371/journal.pbio.1001871.g003
Human Metabolome Evolution
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Among the 47 pathways that contained an excess of human-
specific metabolic changes supported by enzyme expression, 20
were found in the PFC and 9 in skeletal muscle (Tables S12, S13).
Based on shared metabolites, these pathways could be further
grouped into functional units. Human-specific metabolic changes
in the PFC included two such units: (i) translational metabolism
(valine, leucine, and isoleucine degradation, selenocompound
metabolism, aminoacyl-tRNA biosynthesis); and (ii) neurotrans-
mitter signaling (dopaminergic synapse, cocaine and amphetamine
addiction) (Figure 4a, Table S14, Figure S10). In muscle,
functional units partially overlapped and reflected human-specific
changes in: (i) carbohydrate metabolism (propanoate metabolism,
pentose and glucuronate interconversions, glycolysis/glucogene-
sis); (ii) energy production (oxidative phosphorylation); and (iii)
amino acid metabolism (histidine, b-alanine metabolism)
(Figure 4a, Table S15, Figure S11). Additional human-specific
metabolic changes representing separate functional units were also
observed in other tissues (Tables S16, S17, S18, Figure S12).
Extent of Environmental Effects on Metabolome
Composition
Could the stark excess of human-specific metabolic changes
found in some of the examined tissues be caused by
environmental factors, such as diet, stress, or physical activity?
To address this, we performed metabolome measurements in
12 additional macaque monkeys (male, 2–14 years old) that
were subjected to conditions designed to reproduce some
aspects of the modern human lifestyle. Specifically, the test
macaques were placed indoors in solitary standard size cages
with no dietary change (stress and exercise factors: condition 1,
n= 6) or with an additional dietary change to a cooked diet
with high sugar and fat content (stress, exercise, and diet
factors: condition 2, n= 6) for a 1-month period (Table S2).
Similar dietary changes introduced over a shorter time interval
in mice were previously shown to reproduce some of the gene
expression differences observed between human and chimpan-
zee livers [10]. Prior to this treatment, the test macaques, as
well as all other macaques used in this study (standard
condition: controls, n= 17), were fed a balanced plant-based
diet and housed in family groups in spacious outdoor
enclosures. Environmental differences between test macaques
and macaques kept at standard conditions had only a modest
effect on metabolite concentrations: a total of 37 and 78
metabolic peaks were affected in at least one of the five tissues
by condition 1 and condition 2, respectively (permutation p,
0.01, Figure 4b). By contrast, an average of 3,674 and 4,840
metabolic peaks showed equally significant differences in
comparisons between control macaques and six randomly
selected chimpanzee or human individuals, respectively
(Figure 4b, Figure S13). The metabolic changes that were
induced by environmental effects showed significant enrich-
ment in 19 KEGG pathways (permutation p,0.01, Table S19)
containing a total number of human-specific metabolic change
(68 peaks) significantly higher than expected in randomly
sampled pathways (permutation p,0.05). The significant
overlap between environmentally induced and human-specific
metabolic changes indicates that, despite the limited scope and
duration of the environmental change, it nevertheless did
capture some of metabolic effects of the modern human
lifestyle. The extent of metabolic changes induced by environ-
mental perturbation was, however, limited and constituted less
than 3% of all human-specific metabolic changes identified in
our study.
Muscular Strength Differences among Primates
The relatively small effect of the short-term environmental
changes on metabolite concentrations in macaque tissues indicates
that the extraordinary human-specific metabolic divergence
observed in skeletal muscle, PFC, and brain might reflect the
phenotypic differences between humans and other species. We
hypothesize that rapid metabolic evolution in brain and skeletal
muscle is associated with unique cognitive and physical abilities of
humans. While cognitive functions clearly distinguish humans from
other primates, to our knowledge only anecdotal observations exist
suggesting that human muscular strength could be inferior to that of
other primates [11–15]. To investigate this, we conducted a series of
experiments aimed at providing an approximate estimate of
muscular strength in a pulling task accomplished by humans
(n=42), chimpanzees (n=5), and macaques (n=6) (Movie S1). The
task consisted of pulling suspended adjustable weights in a setup
involving both upper and lower parts of the body and conducted in
a procedure allowing us to estimate the maximum pulling strength
of an individual. In this test humans showed substantially inferior
performance compared with chimpanzees and macaques, with an
average strength difference of almost 2-fold (Wilcoxon test, p,
0.001, Figure 4c, Table S20). Prolonged training is known to
increase human strength [16], therefore the tested humans included
16 individuals engaged in regular physical activities, among them
five university team basketball players and four professional
climbers. By contrast, all tested nonhuman primates were raised
in captivity and were never subjected to physical training. Many
additional factors including ones potentially favoring nonhuman
primates, such as difference in muscle mass distribution between
front and hind limbs [17,18], as well as ones favoring humans, such
as motivation to perform, could not be accounted for in our
experiment. The inability to control nonhuman primates’ motiva-
tion hinders the exact quantification of the muscular strength
difference between humans and nonhuman primates, even in a
highly controlled experimental setup. Nonetheless, our results
indicate the existence of systematic differences in muscle perfor-
mance between humans and nonhuman primates.
Discussion
Our study provides several novel insights into the nature and
the potential mechanisms of metabolic evolution. First, we
demonstrate that while metabolic divergence among mammalian
species tends to reflect genetic distances among species, stark
exceptions to this rule exist. Specifically, we show that the
metabolomes of PFC and skeletal muscle have undergone 4- and
7-fold greater divergence, respectively, on the human evolutionary
lineage than expected from genetic divergence. Notably, this
observation contrasts with evolutionary divergence at the tran-
scriptome level where overall transcriptome divergence largely
follows genetic distances in all tissues (Figure S14).
Second, we show that metabolite concentrations are largely
buffered against environmental changes, such as temporary
change in diet, physical activity, and living conditions. While this
is true for tissues assessed in our study—brain regions, kidney, and
muscle—this observation might not apply to tissues closely
interacting with the environment, such as liver and blood.
Moreover, exposure to altered environmental conditions over a
longer time span could result in more pronounced
changes. Nevertheless, the 2 months’ exposure of macaques to
‘‘human-like’’ environmental conditions did recapitulate some
human-specific metabolic changes, indicating the relevance of our
environmental tests.
Human Metabolome Evolution
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The third and perhaps most unexpected observation is a striking
excess of human-specific metabolic divergence in skeletal muscle.
While excess of human-specific metabolic divergence in brain or
brain regions such as PFC might relate to cognitive functions
unique to humans, the functional significance of extreme
metabolic divergence of human skeletal muscle is less apparent.
Our results suggesting a major difference in muscular strength
between humans and nonhuman primates provide one possible
explanation for this phenomenon. In humans, muscle tissue is
known to have variable fiber-type composition, reflecting differ-
ences in individuals’ physiology and physical activity [19]. Since
different muscle fiber types have different functional and metabolic
properties [20], systematic difference in fiber-type composition
between human and other primate species could explain our
observations of extensive metabolic differences and reduced
human muscular strength. To assess this hypothesis, we measured
fiber-type composition in nine adult chimpanzee individuals
(Table S21). Variation in fiber-type composition observed among
chimpanzees was, however, indistinguishable from that observed
among humans [19]. Thus, differences in fiber-type composition
between humans and nonhuman primates are not likely to explain
the extensive metabolic divergence, as well as difference in
strength, observed in our study. Further experiments are needed to
investigate the exact extent of muscle performance differences
between humans and nonhuman primates, as well as the link
between changes in muscle performance and muscle metabolite
composition on the human lineage. On the molecular level, such
experiments could involve isolation of individual muscle types or
functional groups and testing of their contractile properties. On
the organism level, more controlled experiments could inspect
recruitment of particular muscles in motion and quantify their
performance based on their volume and level of activation.
While the molecular mechanism linking metabolic divergence
with changes in muscular strength on the human evolutionary
lineage cannot be determined based on our observations alone, we
hypothesize that metabolic evolution of human muscle and brain
metabolomes may have occurred in parallel. Studies demonstrat-
ing a connection between aerobic exercise and cognitive
performance in humans of different age indicate that these two
organs might be metabolically related [21]. Furthermore, it was
also previously suggested that rescaling of energetically expensive
organs, such as the gut, allowed the development of a larger brain
in human evolution [4]. Our results indicate that the reallocation
of energy to energetically costly human brains may have required
further decrease in energy expense in the skeletal muscle, at least
during peak performance. Combined with previous observations
of decreased bone robustness potentially reflecting a decline in
muscular strength on the human evolutionary lineage [22], it is
plausible that human brain and muscle were evolving in a
reciprocal manner to adjust to the increasing energy demands of
the growing brain [5] and to adapt to new types of physical
activities requiring greater endurance, both characteristic of
modern humans [6]. While differences in muscle energy
consumption between humans and other primates are currently
unknown, we speculate that metabolic coevolution of muscle and
brain may require either an overall decrease in muscle energy
consumption or, alternatively, a shift to alternative energy sources,
such as lipids, thus realizing more glucose for an energy-
demanding human brain. Accelerated changes in metabolite
concentrations in brain and skeletal muscle on the human
evolutionary lineage may, therefore, represent some of the
molecular underpinnings of this evolutionary process.
Materials and Methods
Ethics Statement
The studies were reviewed and approved by the Institutional
Animal Care and Use ethics committee at the Shanghai Institute
Figure 4. Functions of the human-specific metabolites, envi-
ronmental effects, and muscle strength experiments. (a)
Functional units of KEGG pathways containing significant excesses of
metabolites with human-specific concentration profiles in PFC and
skeletal muscle. Columns represent metabolites showing human-
specific concentration profiles in these tissues. Rows represent KEGG
pathways enriched in the respective metabolites. Colors show higher
(red) and lower (blue) concentration levels in humans compared with
the other two primate species. Only pathways supported by human-
specific expression of enzymes are shown. Metabolites directly linked to
the enzymes with a human-specific expression profile in these tissues
are indicated by darker shades of red and blue. Numbers and
borderlines of different shades of gray indicate metabolite groups
showing correlated concentration profiles across multiple pathways.
Plotted metabolites, pathways, and metabolite groups are listed in
Tables S14, S15 and further illustrated in Figures S10, S11. (b) Numbers
of metabolite peaks differentiating humans, chimpanzees, and ma-
caques subjected to environmental condition 1 (C1: physical activity
deprivation), and macaques subjected to environmental condition 2
(C2: high nutrition and physical activity deprivation) from the control
macaques in any of the five tissues (t-test, p,0.01). Numbers of peaks
showing significant concentration differences between control ma-
caques and humans or chimpanzees were estimated using six randomly
chosen human or chimpanzee individuals. The error bars show 0.05 and
0.95 quintiles of the significant peak number distributions calculated by
randomly sampling six human or six chimpanzee individuals 1,000
times. (c) Pulling strength of humans, chimpanzees, and macaques
normalized by individual body weight. The shape of the symbols
represents the individual’s sex: circles: females, diamonds: males. Empty
symbols represent trials measured using the apparatus built in the
Leipzig primate center, filled symbols those measured using the
apparatus built in Shanghai. The size of the symbols is proportional to
the individual’s age normalized by the maximal life expectancy of the
species: humans: 120 years, chimpanzees: 60 years, macaques: 40 years.
Up to three of the best results per individual are shown. Asterisks
indicate the significance of muscle strength difference between
humans and the other two species (Wilcoxon test, p,0.001). The
highest measurement of each individual was used in the p-value
calculation.
doi:10.1371/journal.pbio.1001871.g004
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for Biological Sciences. For all teenagers participating in this study,
we obtained written consent from their parents in addition to the
subjects’ assent.
Samples
Human samples were obtained from the National Institute of
Child Health and Human Development (NICHD) Brain and
Tissue Bank for Developmental Disorders at the University of
Maryland, the Netherlands Brain Bank, China’s Wuhan Xiehe
Hospital, and the Chinese Brain Bank Center. Written consent for
the use of human tissues for research was obtained from all donors
or their next of kin. All subjects were defined as healthy controls by
forensic pathologists at the corresponding tissue bank. All subjects
suffered sudden death with no prolonged agonal state. Chimpan-
zee samples were obtained from the Alamogordo Primate Facility,
New Mexico, USA, the Anthropological Institute & Museum of
the University of Zu¨rich-Irchel, Switzerland, and the Biomedical
Primate Research Centre, the Netherlands. Rhesus macaque
samples were obtained from the Suzhou Experimental Animal
Center, China. All nonhuman primates used in this study suffered
sudden deaths for reasons other than their participation in this
study and without any relation to the tissue used. Mouse samples
were obtained from the mouse facility at Shanghai Institute for
Biological Sciences. All mouse individuals were from the C57/BL6
strain with no genetic modifications. Since mouse measurements
were used solely to compare the pace of metabolic and genetic
divergence among species, underestimation of metabolic and
genetic variation within mouse species because of their genetic
homogeneity does not affect the main results of our study.
The PFC samples were dissected from the anterior part of the
superior frontal gyrus, a cortical region approximately corre-
sponding to Brodmann area 10. The V1 samples were dissected
from the calcarine cortex (human and chimpanzee) or the occipital
lobe (macaques), corresponding to Brodmann area 17. The CBC
samples were dissected from the lateral part of the cerebellar
hemispheres. In all brain samples we took special care to dissect
gray matter only. The kidney samples were dissected from the
renal cortex. Muscle tissue was dissected from thigh skeletal
muscle, mainly vastus lateralis. All tissues were snap-frozen after
dissection and stored at 280uC without thawing.
Each tissue sample was of approximately 100 mg of weight and
was extracted from the frozen postmortem tissue on dry ice
without de-freezing. The tissue samples were first powdered using
a mortar and pestle cooled by liquid nitrogen and then separated
into two parts for the metabolite and RNA extraction procedures.
Postmortem Samples
In order to identify metabolites affected by postmortem delay,
we collected tissue samples from two macaque monkeys that were
dissected and frozen 4–6 hours after death (postmortem samples).
Other macaques used in this study had a postmortem interval of
less than 15 minutes.
Condition 1 and Condition 2 Treatments
To assess the environmental effects on the measured metabo-
lites, we collected samples of two additional groups of macaques
fed a calorie-rich diet and exposed to limited physical activity.
Twelve male macaque monkeys were used for this purpose. All
selected monkeys had no medical history of abnormal behavior
and were healthy, based on biochemical and blood tests. The
monkeys were randomly assigned to three groups, control (three
individuals), condition 1 (six individuals) and condition 2 (six
individuals). For a period of 4 weeks, monkeys from the control
group continued with their routine lifestyle while monkeys from
the other two groups were kept in special conditions.
Monkeys from the control group were maintained on a standard
ad libitum feeding regimen, with two meals each day at 900 and
1600 hours, consisting of 1,100 calories (20 biscuits) of Purina
High Protein Monkey Diet, jumbo size (W.F. Fisher and Son Inc.),
and one-quarter piece of fresh fruit for the morning meal. These
individuals were housed in spacious group cages hosting family
groups of about 20 individuals and providing open and walled
living spaces of about 120 m3 in total.
Macaques from condition 1 and condition 2 groups were
transferred from the standard living conditions (control condition)
into individual standard-size cages located in a temperature-
controlled room (2462uC) with lights on 12 hours each day (700–
1900). The cage size was close to 1 m3 and largely limited their
space for movement. The diet of condition 1 monkeys was kept
unchanged and was the same as the diet of monkeys from the
control group. The diet of condition 2 monkeys was based on
cooked food, consisting of 100 g rice, one medium size egg, 50 g
peanuts, 15 g sugar, and 100 g potato daily, which amounted to
the total energy of approximately 1,060 calories. The animals
accepted this type of food and the diet was maintained unchanged
for 1 month until the animals were humanely killed.
The studies were reviewed and approved by the Institutional
Animal Care and Use ethics committee of the Shanghai Institute
for Biological Sciences.
GC- and LC-MS Sample Preparation and Measurements
Metabolites were extracted from the frozen tissue powder by a
methanol: methyl-tert-butyl-ether (1:3 [v/v]) extraction according
to Giavalisco et al. [23]. In brief, 50 mg of frozen powdered tissue
material was re-suspended in 1 ml extraction solution containing
0.5 mg of corticosterone, 1.5 mg of 1,2-diheptadecanoyl-sn-glycero-
3-phosphocholine (Avanti Polar Lipids, 850360P), 0.5 mg of 13C
sorbitol and 0.25 mg of ampicillin. The samples were incubated for
10 min at 4uC on an orbital shaker. This step was followed by
ultrasonication in a bath-type sonicator for 10 min at room
temperature. Finally, the insoluble tissue material and the
precipitated proteins were pelleted by a centrifugation step
(5 min; 14,000 g) and the supernatant transferred to a fresh
2 ml Eppendorf tube. To separate the organic from the aqueous
phase, 500 ml of an H2O:methanol mix (3:1 [v/v) was added to the
supernatant, vortexed, and centrifuged (5 min; 14,000 g). Subse-
quently, 500 ml of the upper, organic phase, plus 650 ml of the
polar phase (150 ml for GC-MS and 500 ml for LC-MS) were
collected to three 1.5 ml Eppendorf tubes. Each aliquot was
concentrated to complete dryness in a speed vacuum centrifuge at
room temperature. Extract derivatization and GC-MS measure-
ments were performed according to Lisec et al. [24].
In the LC-MS datasets, in addition to the individual tissue
samples, we measured mixtures of tissue samples (pooled samples).
Pooled samples were measured after every 40th sample, providing
us information on system performance (sensitivity and retention
time consistency), sample reproducibility, and compound stability
over the time of the MS-based analysis.
CE-MS Sample Preparation and Measurements
Metabolites were extracted from the frozen tissue powder by
1 ml methanol containing 20 mM each of L-Methionine sulfone
(WAKO: 502-76641), 2-Morpholinoethanesulfonic acid, monohy-
drate (DOJINDO 349-01623), and sodium d-camphor-10-sulfonic
acid (WAKO: 037-01032). Then, 0.5 ml of lysate was transferred
to an Eppendorf tube containing 500 ml chloroform and 200 ml
water. After 30 seconds of vortexing and 15 min of centrifugation
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at 4uC, 300 ml, the aqueous phase was transferred to an
ultrafiltration tube (Millipore). The filtered liquid was concentrat-
ed to complete dryness in a speed vacuum for 3 hours at 35uC.
The remaining 0.5 ml tissue lysate was incubated at room
temperature for 30 min after adding 4 ml of chloroform, 1.4 ml
methanol, and 0.1 ml 30 mM sphingomyelin (Avanti) in a 10 ml
glass tube. After 10 min of centrifugation, the supernatant was
collected and dried in a speed vacuum.
RNA-seq Sample Preparation and Measurements
From a total set of tissue samples used in metabolite
measurements, we selected, based on the RNA preservation, a
subset of six samples from each species and each tissue (120
samples in total) for the analysis of gene expression. Total RNA
was extracted by a TRIzol (Invitrogen) procedure according to the
manufacturer’s instructions. All RNA quality was assessed using an
Agilent 2100 Bioanalyzer. Only samples with high RNA integrity
values were used in this study.
Sequencing libraries were prepared using the TruSeq RNA-seq
Sample Preparation Kit (Illumina) according to the manufactur-
er’s instructions. Briefly, polyadenylated RNA was isolated using a
poly-dT bead procedure and then chemically fragmented and
randomly primed for reverse transcription. After second-strand
synthesis, the ends of the double-stranded complementary DNA
were repaired. After 39-end adenylation of these products,
Illumina Single-End Sequencing adapters were ligated to the
blunt ends of the cDNA fragments. Ligated products were then
PCR-amplified (15 cycles). The RNA-seq libraries were sequenced
(100 cycles) on the Illumina HiSeq 2000 platform.
Peak Alignment
What we define as a peak throughout this manuscript is an
individual mass trace together with isotopes (mass spectroscopy
feature) at a distinct retention time in the chromatographic sepa-
ration (chromatographic feature). LC-MS peaks were aligned
across samples according to Giavalisco et al. [23], using the
Refiner MS software package version 6.0 (GeneData). GC-MS
peaks were extracted and annotated using msPeak (Steinhauser et
al., unpublished). In this procedure the GC-MS chromatograms
were exported as NetCDF files (ANDI MS format) using Leco
ChromaTOF software (version 3.25) with the following settings:
baseline subtraction just above the noise (1.0), peak width
broadening with width-to-time (w/t) of 3.5/0 seconds—6.0/
1,400 seconds, and without smoothing. Peak smoothing (nine
data points) and alignment were performed within msPeak for
each mass trace separately using peak spread and peak gap to
neighboring peaks.
To limit the potential technical artifacts, we employed a
multistep peak filtering procedure to all MS datasets. The LC-MS
datasets were filtered according to the following criteria:
1. retention time (RT) $0.6 min,
2. peaks present in $80% of pooled samples with an intensity of
$1,000 arbitrary units (AU),
3. peaks showing consistent concentration levels in the first two
pooled samples of the LC-MS datasets, which corresponds to
the maximal time that any of the samples were kept in the
autosampler before measuring,
4. peaks present at the level of $10,000 AU in $50% of samples
of any particular species and tissue.
Before applying the last filtering criterion, outlier samples
were removed from the datasets. Outliers were identified based
on PCA plots and included nine samples in the [+]LC-MS and
[2]LC-MS datasets. This filtering procedure resulted in 4,458
[+]LC-MS peaks and 2,956 [2]LC-MS peaks satisfying all the
criteria, which corresponds to 6% of the initially registered
peaks.
The GC dataset was filtered according to following criteria:
1. peaks distinct from the background, which we define as a
measurable peak width at the level of 10% of its apex,
2. RT of a peak in all samples within the range of 2 min around
the median RT of this peak,
3. RT outside of the range of 0.75 min of the RTs of any of the
used internal standards (IS) RTs or, if the peak shares the same
mass with any of the IS, outside of the range of 1.5 of the RT of
this IS,
4. peak level $3,000 AU in $50% of samples of samples of any
particular species and tissue,
5. peaks with the same mass and RT differing by #0.5 were
classified as overlapping and removed.
Before applying criteria 4, nine outlier samples identified based
on PCA analysis were removed from the dataset. The filtering
resulted in 3,201 peaks in this dataset, representing 9% of the
initial peak set.
In the quantitative part of our analysis, we used the entire set of
unannotated peaks satisfying the above quality criteria. This set
was narrowed down to the identified molecules in further
functional analysis.
Normalization
All peak concentration values were log transformed and quintile
normalized. The normalization was performed on groups of
samples belonging to the same tissue, an approach that was
selected out of several other methods [25] according to normal-
ization-quality measures of peak variation within samples of the
same tissue and species.
RNA-seq Reads Alignment and Mapping
We used Bowtie2 [26] with a default parameter setting to align
the reads to the respective genomes: human version hg19, chimp
panTro3, rhesus rheMac2, and mouse version mm9 from the
Ensembl66 [27]. Bowtie2 reports up to two possible alignments
for each read. For further analysis we kept reads with alignment
score .150 and, among those that mapped to two locations, only
those with a difference in alignment score $5. Among reads that
mapped to an exon and exon junction, those with higher scores
were kept. The one that mapped to an exon was kept if the scores
were equal. Following this procedure, we obtained 24.1 M
mapped reads per sample on average. Gene expression was
quantified as (N*100)/(L-99) where N is the number of reads
aligned to gene exons and L is the total length of the gene exons.
We used the liftOver tool [28] to map the human genome onto
the genomes of the other three species. Comparison of gene
expression among three primate species was based on the genome
mapping reported by the liftOver tool. For reconstruction of the
mouse and human junctions, we additionally used mouse genome
annotation and homology information. In the comparison of
mouse to other species, we restricted the set of genes’ exons to
those that could be mapped among all four species. In the
comparison of gene expression among primates, we used a larger
set of genes’ exons that could be mapped among the three
primate species. As a cutoff for a minimal level of expression of
the analyzed genes, we selected the 5% quintile of all gene
nonzero expression levels in all samples.
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Hierarchical ANOVA
We used analysis of variance (ANOVA) to identify metabolite
peaks showing significant concentration level differences among
species or tissues, or significant species–tissue interaction term (F-
test p,0.01). ANOVA was performed on all samples and on the
samples of primates only (primate test). For peaks showing a
significant proportion of variation explained by species and
species–tissue terms in ANOVA, we performed an additional t-
test to identify the species in which the metabolite peak
concentration levels were significantly different from the other
species. Metabolite peaks significant in the primate ANOVA test
were tested for peak specificity to any primate species; peaks
significant in the ANOVA test performed on all species samples
were tested for mouse-specific concentration levels. In the t-test,
samples from each tissue were tested separately. In each test, peak
levels of a given species were compared with the peak levels in the
samples of the remaining species—other primates if the tested
species were primate, all primates if the tested species was mouse.
ANOVA and t-test significance levels were corrected for multiple
testing and the FDR levels at different nominal test significance
levels were estimates by sample label permutations. Peaks showing
p,0.01 and FDR,5% in 1,000 permutations were considered
significant.
In addition to the initial set of five tissues that the samples were
collected from, we defined two composite neural tissues obtained
by in silico grouping of specific brain regions: cortex tissue was
defined as a combination of two cortical regions: PFC and V1;
brain tissue was defined as a combination of all three brain
regions. In the t-test used to identify species-specific peak
concentration levels in these tissues, all samples of the composite
tissues were used.
In analyses of species-specific metabolic changes unique to the
five individual tissues used in this study, we excluded metabolite
peaks with concentration levels specific to a given species and
showing the same direction (increase or decrease) of change in
multiple tissues within three tissue groups: (i) PFC and V1; (ii)
cortex and CBC; (ii) brain, kidney, and muscle.
Identification of Environment- and Postmortem Delay-
Induced Metabolite Concentration Changes
In order to identify metabolite peaks with concentration levels
altered by changes in diet, stress, and physical activity in
macaques, we performed a t-test on the tissue samples from
condition 1 (n=6) or condition 2 (n=6) macaque individuals and
the control tissue samples of all macaque individuals with
unaltered environmental conditions (n=17) in each tissue. Peaks
showing significant difference (t-test p,0.01, permutation p,0.01)
in condition 1 or condition 2 samples and showing the same
direction of change in the human samples (elevated or decreased)
were classified as affected by environmental change in condition 1
or condition 2, respectively. The overlap with human-specific
metabolite concentration changes was determined as an overlap of
environment-induced changes in a given tissue, and metabolite
concentration differences showing the same direction (elevated or
decreased) in this tissue in the human samples as compared with
the control macaques.
In order to identify metabolite peaks with concentration levels
altered by postmortem delay, we quantified the differences in peak
concentration levels in each tissue between the macaque samples
from individuals living in control conditions collected with 4- and
6-hour postmortem delay (n=2) and macaque samples from
individuals living in control conditions collected with less than
15 min postmortem delay (n=17). Peaks showing concentration
differences in the top or bottom 5% quintile of all peak differences
between postmortem samples and control samples were excluded
from further analyses in the respective tissue.
Clustering of Metabolite Concentration Differences
among Tissues
We performed hierarchical clustering with complete linkage of
metabolite peaks. Silhouette value was used to choose the best
clustering. Peaks in the smallest clusters, the total size of which
were ,10% of all peaks within a metabolite class, were excluded
from further cluster analysis.
Gene Expression Analysis
Based on the gene expression measurements of the 120 tissue
samples we searched for genes showing expression profiles specific
to a particular tissue and specific to a particular species in a given
tissue. For each gene we calculated the mean difference of its
expression level between every pair of tissues and between every
pair of species in each tissue. Genes showing differences in
expression level in a particular tissue compared with all other
tissues, or species compared with all other species in the same
tissue, within the upper or lower 5% quintile (10% quintile in the
tissue comparison) of the difference distribution were classified as
tissue-specific or species-specific in a given tissue respectively.
Peak Annotation and Pathway Analysis
We used accurate mass searches with a mass tolerance of
5 ppm, allowing [M+H], [M+NH4] and [M+Na] as possible
adducts in positive ionization mode samples and [M2H] and [M+
Formic acid-H] in negative ionization mode samples [23]. The
obtained m/z values were then searched against the HMDB
database [29] for annotation of the [+]LC-MS and [2]LC-MS
datasets. For the annotation of the GC-MS dataset, all of the GC-
MS dataset chromatograms were processed and aligned as
described previously [30,31] using several reference compound
libraries of commercially available authentic standards measured
on the employed GC-MS system [31–33].
We used the resulting annotation to assign the metabolites to
specific KEGG [34] pathways and inspected metabolic pathways
overrepresented in the two types of metabolite groups found in our
analysis: clusters of all peaks and peaks showing species-specific
concentration levels in different tissues. We used metabolite
annotation from both HMDB and KEGG databases to link the
metabolites to metabolic pathways. Hypergeometric test (p,0.05,
permutation p,0.05) was used to identify pathways with
significant overrepresentation of metabolites belonging to a
specific metabolite group, as compared with other metabolites
measured in our study. In the search for KEGG pathways with
significant overrepresentation of metabolites showing species-
specific concentration profiles, we used all metabolites measured
in this study as a background for the hypergeometric and
permutation tests. In the search for KEGG pathways with
significant overrepresentation of metabolites from 13 metabolite
clusters, we used all metabolites belonging to clusters with
concentration profiles specific to tissues different from the tissue
of the tested cluster as a background for the hypergeometric and
permutation tests.
Agreement between Metabolite and Gene Expression
Data
We assessed the agreement between metabolite concentration
levels and expression of their linked enzymes. Among genes
detected in the transcriptome data, we extracted those reported by
the KEGG database as enzymes linked, based on reaction
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information, to the metabolites measured in our metabolite
datasets. Next, we tested the overrepresentation of enzymes with
expression profiles matching concentration profiles of metabolites
among: (i) enzymes annotated in pathways with significant
overrepresentation of metabolites showing species-specific concen-
tration profiles in a tissue, as well as pathways with significant
overrepresentation of metabolites from tissue-specific metabolite
clusters; (ii) enzymes directly linked to metabolites based on
KEGG annotation in the tissue-specific clusters or the species-
specific metabolites.
In the pathway-based analysis (i) we tested both the overrepre-
sentation of pathway enzymes with a corresponding expression
profile, as well as pathway enzymes with a corresponding expression
profile directly linked to the pathway metabolites with species-
specific concentration profile or belonging to a tissue-specific cluster.
In the link-based analysis (ii) we tested only the overrepresentation
of enzymes showing corresponding expression profiles directly linked
to the cluster metabolites or species-specific metabolites in KEGG
annotation. In this test, in an iterative procedure, we randomly
sampled sets of metabolites of the same size as the tested metabolite
group—species-specific or tissue-specific cluster metabolites—and
calculated the proportion of enzymes of the matching expression
profile among all enzymes connected to the sampled metabolite. In
the random permutations, we only used metabolites reported to
interact with any of the enzymes measured in our transcriptome
analysis. In the analysis of clusters and cluster pathways, the
metabolites were sampled from all metabolites belonging to clusters
with concentration profiles specific to a tissue different from the
tissue of the tested cluster. The proportion of enzymes with the
corresponding expression profile linked to the tested metabolite
group—pathway (i) or cluster (ii)—was compared with the
proportion obtained in the sampling test.
Metabolite and Pathway Functional Groups
To facilitate functional analysis of metabolites showing species-
specific concentration profiles in different tissues and KEGG
pathways with significant overrepresentation of these metabolites,
we grouped pathways according to shared metabolites into
functional units. Following the pathway enrichment analysis, in
each species-specific metabolite group, metabolites belonging to
two or more KEGG pathways and sharing more than two-thirds
of the overrepresented pathways were incrementally grouped into
functional units until no two metabolites sharing sufficient
numbers of pathways could be grouped together. This process
resulted in functional units and metabolite groups representing
different metabolic functionality.
Fiber Typing of Chimpanzee Muscle Samples
The frozen biopsy samples were placed in a 9 mg/ml sodium
chloride solution and stored at 5uC for 30 min [35]. Afterwards
excess moisture was thoroughly removed from the samples with
absorbent paper towels before the samples were mounted in an
embedding medium (Tissue-Tek OCT Compound, Sakura
Finetek) and frozen in isopentane precooled with liquid nitrogen.
Four serial 10 mm-thick sections were cut at230uC, preincubated
at pH 4.37, 4.6, and 10.3 and stained for myofibrillar ATPase
reactions at pH 9.4 [36]. Subsequently, fibers were classified
under light microscopy as type I, IIa, and IIx fibers.
Muscle Strength Measurements
We designed an experimental setup for testing muscular
strength of humans, chimpanzees, and macaques that would be
applicable to all three species to a similar extent. Specifically, the
measurements were conducted using a simple mechanical
apparatus consisting of a sliding shelf attached to a handle on
one side, and suspended adjustable weights on the other side of the
shelf. In chimpanzee and macaque experiments, the handle was
placed inside a cage and the individual was encouraged to displace
the shelf (by pulling from the handle) to bring food within her
reach. Pulling on the handle required the individual to lift the
respective weight attached to the shelf by engaging both upper and
lower body parts. The strength of the pull was registered by an
electronic scale placed on the shelf and attached to a rope
connecting the handle and the weight. In order to register the
maximal pulling force, the electronic scale was continuously filmed
by a camera placed on the moving shelf. With each individual’s
successful pull, the amount of weight attached to the device was
increased. After several failed attempts by an individual to pull a
certain weight, the amount of food on the device was increased.
The maximum pull force measured by the electronic scale divided
by the individual’s body weight was used as a normalized measure
of an individual’s strength.
For nonhuman primate experiments, six healthy male ma-
caques of 5–6 years of age with body mass 7–10 kg and five
chimpanzees (three females and two males) of 8–11 and 37 years of
age and body mass 32–55 kg were tested. All selected individuals
had no medical history or reported abnormal behavior and were
healthy during the strength experiments. Macaques were bor-
rowed from breeding facilities at Suzhou Experimental Animal
Center, China, where the tests were performed, and returned to
the breeding facility after the tests. Macaque monkeys, prior to the
muscle tests, were housed in spacious enclosures of approximately
120 m3. Each enclosure hosted a group of approximately 20
individuals and contained multiple objects used for climbing.
Chimpanzee tests were performed at the Wolfgang Ko¨hler
Primate Research Center of the Max Planck Institute for
Evolutionary Anthropology in Leipzig Zoo, Germany. The Zoo
enclosures are large and contain objects imitating a natural
chimpanzee environment, including climbing facilities.
For human experiments, a total of 42 human individuals were
tested. Thirty-six of them were tested using the Suzhou apparatus
and eight using the Leipzig apparatus. Human individuals
included 29 adults 17–34 years of age with a wide span of body
mass between 42 and 127 kg (mean 64 kg615 kg SD). Among
these individuals, four were professional climbers and 12 were
engaged in regular physical activities. In addition, we tested 15
teenagers (13–14 years, seven females, eight males, body mass 43–
69 kg, mean 53 kg67 kg) with ages corresponding to the ages of
the tested macaques and some of the tested chimpanzees. For all
teenagers participating in this study, we obtained written consent
from their parents in addition to the subjects’ assent.
RNA-seq Data
All RNA-seq data were uploaded to the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession
number GSE49379.
Supporting Information
Figure S1 Percentage of peaks affected by postmortem
delay among metabolic peaks in different datasets, as
well as all peaks combined (ALL).
(PDF)
Figure S2 Agreement between metabolite concentration
profiles across the four species measured using LC-MS
and GC-MS data and the independently measured CE-MS
dataset. The colored bars represent observed distribution of
Pearson correlation coefficients between datasets in each tissue; the
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gray bars represent distributions obtained by 100 random permuta-
tions of metabolite labels. In all tissues the correlations between
concentration profiles measured by different technologies is signifi-
cantly higher than expected by chance (Wilcoxon test, p,0.001).
(PDF)
Figure S3 PCA plots based on normalized intensities of
all metabolite peaks detected in the three datasets
separately.
(PDF)
Figure S4 Silhouette values of the clustering of the
peaks according to their concentration profiles among
tissues within the metabolite dataset. The silhouette value
reflects the quality of clustering favoring well-separated compact
clusters. The asterisks indicate the highest silhouette values
observed for 19 clusters. Among them, 13 clusters were sufficiently
large, i.e., cumulatively contained more than 90% of all clustered
peaks, and were used in further analysis.
(PDF)
Figure S5 Metabolite concentration profiles within the
clusters pictured in Figure 2a. Samples are ordered along the
X-axis according to tissue as indicated below the axis. Peak
concentration profiles normalized by their Euclidian norm are
shown with gray lines. The average concentration profile of all
peaks within a cluster is traced with colored lines. The star signs
show average normalized concentration levels of all cluster peaks
within one tissue. The total number of metabolite peaks and
number of annotated peaks within a cluster are shown above each
plot. The coloring of the profiles corresponds to the coloring in
Figure 2a.
(TIFF)
Figure S6 PCA plots based on normalized expression
levels of 14,875 transcripts (left) and 3,537 metabolic
enzymes (right) measured using RNA-seq. The plots show
120 tissue samples from the four species, six samples per species
per tissue, selected among all samples used in metabolite
measurements. Each diamond represents a sample colored
according to tissue identity as indicated in the legend. The
transcripts used in principle component calculation were detected
in at least one tissue of one species above the 5% quintile of all
detected transcripts.
(PDF)
Figure S7 Proportions of metabolite peaks showing
species-specific concentration changes among the pri-
mates in different tissues. The phylogenetic tree above the
bars shows the human (red) and chimpanzee (orange) evolutionary
lineages, as well as the lineage connecting the common ancestor of
humans and chimpanzees with macaques (gray). The colors within
the bars represent proportions of metabolite concentration
changes on the corresponding lineages.
(PDF)
Figure S8 Proportions of metabolite concentration
changes on the four evolutionary lineages. The colors
indicate proportions of peaks showing species-specific concentra-
tion changes on the human (red) and chimpanzee (orange)
evolutionary lineages, as well as the lineage connecting the
common ancestor of humans and chimpanzees with macaques
(gray), and the lineage connecting the common ancestor of
humans, chimpanzees, and macaques with mice (blue). The upper
panel is based on 1,535 annotated metabolite peaks, and the lower
panel on 9,155 metabolite peaks that could not be annotated.
(PDF)
Figure S9 Proportions of metabolite concentration
changes on the primate evolutionary lineages based on
2,505–5,141 metabolite peaks with no zero concentration
values in all individuals of all species in a given tissue.
The colors indicate proportions of peaks showing species-specific
concentration changes on the human (red) and chimpanzee
(orange) evolutionary lineages, as well as the lineage connecting
the common ancestor of humans and chimpanzees with macaques
(gray).
(PDF)
Figure S10 Grouping of species-specific metabolites and
KEGG pathways in PFC. Columns represent metabolites
showing species-specific concentration profiles in PFC;
rows represent KEGG pathways enriched in the respec-
tive metabolites. Colors show higher (red) and lower (blue)
species-specific concentration levels. All pathways, including those
not supported by expression of enzymes, are included in this plot.
Pathways not containing enzymes with matching expression
profile are indicated by lighter shades of red and blue. Metabolites
directly linked to the enzymes with a human-specific expression
profile in these tissues are indicated by darker shades of red and
blue. Numbers and borderlines of different shades of gray indicate
metabolite groups showing correlated concentration profiles across
multiple pathways. The metabolite and pathway information is
further listed in Table S14.
(PDF)
Figure S11 Clustering of species-specific metabolites
and KEGG pathways in skeletal muscle. The plot is
organized as in Figure S10, the metabolite groups are listed in
Table S15.
(PDF)
Figure S12 Clustering of species-specific metabolites
and KEGG pathways in kidney. The plot is organized as in
Figure S10, the metabolite group is listed in Table S17.
(PDF)
Figure S13 Numbers of metabolite peaks differentiat-
ing the control macaque monkeys from humans (hu-
man), chimpanzees (chimp.), macaque monkeys sub-
jected to environmental condition 1 (C1), and macaque
monkeys subjected to environmental condition 2 (C2) in
brain, skeletal muscle, and kidney (t-test p,0.01).
Numbers of peaks showing significant concentration differences
between control macaques and humans or chimpanzees were
estimated using randomly chosen six human or six chimpanzee
individuals, the same numbers as for C1 and C2 macaque
monkeys. The error bars show 0.05 and 0.95 quintiles of the
significant peak number distributions calculated by randomly
sampling six human or six chimpanzee individuals 1,000 times.
(PDF)
Figure S14 Proportions of gene expression change on
the primate evolutionary lineages based on 17,913
transcripts present in all three species. The colors indicate
proportions of transcripts showing species-specific expression level
changes on the human (red) and chimpanzee (orange) evolutionary
lineages, as well as the lineage connecting the common ancestor of
humans and chimpanzees with macaques (gray). Genes showing
differences in expression level in a particular species tissue
compared with all other species in the same tissue, within the
upper or lower 5% quintile of the difference distribution, were
classified as species-specific in a given tissue.
(PDF)
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Movie S1 Movie demonstrating the experimental setup
for the measurements of muscle strength of macaque
monkeys. It contains three example takes of the pulling
individuals and three example takes of the scale measuring the
strength of a pull. Recordings of the scale were used to determine
the maximum pulling strength of individuals.
(MOV)
Table S1 List of tissue samples used in metabolite
measurements. Samples also used for the transcriptome mea-
surements using RNA-seq and additional metabolite measurements
using CE-MS are marked with ‘‘1’’ in the respective columns.
Column ‘‘outliers’’ shows datasets where measurements in a given
sample have failed as revealed by the PCA.
(XLSX)
Table S2 List of samples used to assess effects of
postmortem delay, diet, and physical activity on metab-
olite concentrations. The control samples listed in this Table
represent macaques kept in the same conditions as all other
macaques used in main experiment, and are age-matched with
‘‘condition 1’’ and ‘‘condition 2’’ individuals. These samples were
analyzed separately, as well as combined with the main sample
group in the metabolite concentration analysis.
(XLSX)
Table S3 Effect of postmortem delay on metabolite
concentrations. Numbers of metabolite peaks affected by
postmortem delay across datasets and tissues.
(XLSX)
Table S4 Proportions of metabolite variation explained
by different factors. Shown are percentages of metabolite
peaks with significant proportion of concentration variation
(ANOVA p,0.01) explained by the following factors: tissue,
species, sex, age, and RNA preservation (RNA Integrity Number–
RIN). The number of samples tested was limited to 85 samples for
which the full annotation including RIN was known.
(XLSX)
Table S5 Functional analysis of metabolite variation
among tissues. KEGG pathways with significant overrepresen-
tation of metabolites in 13 metabolite peak clusters, obtained by
grouping metabolite peaks according to their concentration
profiles across tissues.
(XLSX)
Table S6 RNA-seq data summary. The Table lists total
numbers of sequenced reads and proportions of reads mapped to
the genome, for each sample.
(XLSX)
Table S7 List of peaks illustrated in Figure 3c. Table
includes concentration levels of 4,698 metabolite peaks depicted in
Figure 3c in the same order (from left to right) as the primate
samples shown in the Figure. The columns show the concentration
values followed by t-test p-Values conducted for each species in
each tissue. The last column shows annotation of peaks identified
in the database search.
(XLSX)
Table S8 Numbers of peaks showing species-specific
concentration changes in each dataset. The total number of
peaks in the dataset is indicated next to the dataset name,
percentages of peaks in each category are shown in brackets. The
rows show numbers and percentage of changes on different
evolutionary lineages: the human (human) and chimpanzee
(chimp.) evolutionary lineages, as well as the lineage connecting
the common ancestor of humans and chimpanzees with macaques
(macaq.), and the lineage connecting the common ancestor of
humans, chimpanzees, and macaques with mice (mouse).
(XLSX)
Table S9 Excess of human-specific metabolite concen-
tration divergence at different significance cutoffs.
Shown are the ratios of metabolite peaks showing human-specific
concentration changes to peaks showing species-specific changes
on the other evolutionary lineages at different significance cutoffs.
The cutoffs are indicated above the respective part of the Table,
the p-Values are corrected for multiple testing. The lineages are
abbreviated as: the human evolutionary lineage (human), the
chimpanzee evolutionary lineage (chimp.), the lineage connecting
the common ancestor of humans and chimpanzees with macaques
(macaq.), and the lineage connecting the common ancestor of
humans, chimpanzees, and macaques with mice (mouse). The
ratios are based on metabolite peaks from all datasets.
(XLSX)
Table S10 Numbers of metabolites with species-specific
concentration profiles detected in both [+]LC-MS and
[2]LC-MS datasets. The numbers represent the percentage of
overlapping metabolites among all metabolites detected in the
dataset, with the ratio of human-specific to other species-specific
metabolites among the overlapping ones in parentheses. Inf
indicates no overlapping metabolites with concentration levels
specific to a given species was found between the datasets.
(XLSX)
Table S11 Numbers of KEGG pathways containing
significant overrepresentation of metabolites with spe-
cies-specific concentration profiles in different tissues.
The Table shows: (1) all pathways; (2) pathways that contain at
least one enzyme showing species-specific expression pattern that
matches the concentration profile of the pathway metabolites; (3)
pathways in which metabolites and enzymes with matching
species-specific concentration and expression profiles are directly
linked in KEGG annotation; (4) pathways showing significant
overrepresentation of enzymes with matching species-specific
expression profiles either directly or indirectly linked with pathway
metabolites. The lineages are abbreviated as: the human
evolutionary lineage (human), the chimpanzee evolutionary
lineage (chimp.), the lineage connecting the common ancestor of
humans and chimpanzees with macaques (macaq.) and the lineage
connecting the common ancestor of humans, chimpanzees and
macaques with mice (mouse).
(XLSX)
Table S12 KEGG pathways containing significant over-
representation of metabolites with human-specific con-
centration profiles in PFC. The Table lists: pathways names
and IDs, pathway p-Values, numbers of pathway metabolites
showing human-specific concentration profiles, numbers of
enzymes showing human-specific expression, numbers of enzymes
showing human-specific expression and directly linked with
metabolites showing human-specific concentration profiles, as well
as p-Values indicating probabilities of finding equal or greater
numbers of enzymes or linked enzymes in metabolites sets
randomly sampled 100 times.
(XLSX)
Table S13 KEGG pathways containing significant over-
representation of metabolites with human-specific con-
centration profiles in skeletal muscle. The Table lists:
pathways names and IDs, pathway p-Values, numbers of pathway
metabolites showing human-specific concentration profiles, numbers of
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enzymes showing human-specific expression profiles, numbers of pairs
of directly linked enzymes and metabolites with human-specific and
concentration level profiles, as well as p-Values indicating probabilities
of finding equal or greater numbers of enzymes or linked enzymes in
metabolites sets randomly sampled 100 times.
(XLSX)
Table S14 Functional modules comprised of metabo-
lites and pathways showing human-specific changes in
PFC. The modules (metabolite groups) are listed in the order
depicted in Figure S10. For each module, metabolites, pathways
and enzymes are listed. The difference in concentration levels of
each metabolite between humans and chimpanzees and rhesus
macaques is given next to the respective metabolite. The negative
sign of this difference corresponds to lower concentration levels in
humans (shown in blue in Figure S10), while positive sign
corresponds to higher concentration levels in humans (shown in
red in Figure S10).
(XLSX)
Table S15 Functional modules comprised of metabo-
lites and pathways showing human-specific changes in
skeletal muscle. The modules (metabolite groups) are shown
in Figure S11. Organization of the Table is analogous to Table
S14.
(XLSX)
Table S16 KEGG pathways containing significant over-
representation of metabolites with human-specific con-
centration profiles in kidney. The Table lists: pathways
names and IDs, pathway p-Values, numbers of pathway
metabolites showing human-specific concentration profiles, num-
bers of enzymes showing human-specific expression, numbers of
enzymes showing human-specific expression profiles, numbers of
pairs of directly linked enzymes and metabolites with human-
specific expression and concentration level profiles, as well as p-
Values indicating probabilities to find equal or greater numbers of
enzymes or linked enzymes in metabolites sets randomly sampled
100 times.
(XLSX)
Table S17 Functional modules comprised of metabo-
lites and pathways showing human-specific changes in
kidney. The modules (metabolite groups) are shown in Figure
S12. Organization of the Table is analogous to Table S14.
(XLSX)
Table S18 KEGG pathways containing significant over-
representation of metabolites with human-specific con-
centration profiles in brain, cerebral cortex and CBC
(cerebellar cortex). The Table lists: pathway names and IDs,
pathway p-Values, numbers of pathway metabolites showing
human-specific concentration profiles, numbers of enzymes
showing human-specific expression profiles, numbers of pairs
of directly linked enzymes and metabolites with human-specific
and concentration level profiles, as well as p-Values indicating
probabilities of finding equal or greater numbers of enzymes or
linked enzymes in metabolites sets randomly sampled 100
times.
(XLSX)
Table S19 KEGG pathways containing significant over-
representation of metabolites showing concentration
level changes due to environmental treatment in ma-
caques (condition 1 and/or condition 2). Shown are:
overlap with metabolites showing human-specific concentration
profiles and presence of enzymes showing human-specific
expression profiles, as well as statistical significance of these
observations determined by comparison to metabolites sets
randomly sampled 100 times. For comparison, overlap with
metabolites showing chimpanzee-specific concentration profiles is
also shown. Pathways with significant enzyme expression support
are marked in red.
(XLSX)
Table S20 Muscle strength measurements in humans,
chimpanzees, and rhesus macaques. Weight and strength
of an individual’s pull in each testing session is indicated.
Missing sessions are marked in gray, the best result of each
individual is marked in green. Maximal pulling strength
normalized to an individual’s body weight is shown in the last
column.
(XLSX)
Table S21 Fiber-type composition of chimpanzee and
human skeletal muscle. Fibers of different types were counted
in cross-sections of frozen tissue samples from nine adult
chimpanzee individuals. The variation found in the chimpanzee
individuals was compared with variation previously measured in
humans using the same methodology [19].
(XLSX)
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